BUY Emcure Pharmaceuticals LimitedKush Bohra

byKush BohraHorizon: NA (inferred Swing (≤2wk))11 Sept 2026via NDTV Profit (Live)

Entry₹1,965Inferred
Target₹2,095
Stop loss₹1,905-3.05% risk
CMP₹1,978.921h ago
Active+0.71%+5.87%upside left 13d left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 12 Sept, 1:48 pm IST
5 supporting2 neutral1 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·12 Sept · today

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·10 Sept · yesterday

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · 5d ago

(opens in new tab)

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.